BlogTalkRadio uses cookies. By using our services, you're agreeing to our Cookies Policy. Got it

Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

The Pelvic Messenger: Dr. Daniel Clauw

  • Broadcast in Health



Follow This Show

If you liked this show, you should follow PelvicMessenger.

Daniel Clauw is a Professor of Anesthesiology. Medicine (Rheumatology) and Psychiatry  at the University of Michigan (UM). He serves as Director of the Chronic Pain and Fatigue Research CenterDr. Clauw is currently Co-Principal Investigator of the University of Michigan Discovery Site for the Multidisciplinary Assessment of Pelvic Pain (MAPP) network, focusing on identifying the underlying mechanisms for interstitial cystitis and chronic prostatitis.  In addition, he serves as the chair of the MAPP network which includes six discovery sites, as well as a data and tissue coordinating center.

Dr. Clauw attended the University of Michigan for both undergraduate and medical school studies and then completed his Internal Medicine residency and Rheumatology Fellowship at Georgetown University. He joined the faculty at Georgetown University in 1990, and while there, founded the Georgetown Chronic Pain and Fatigue Research Center, and served as the Division Chief of Rheumatology, Immunology and Allergy, and Vice Chair of the Department of Medicine. Since moving to UM in 2001, Dr. Clauw continues his commitment to clinical care and research in overlapping conditions such as fibromyalgia and interstitial cystitis, becoming an internationally known expert in chronic pain, and especially the central nervous system contributions to chronic pain states, performing past or ongoing work in conditions such as low back pain, osteoarthritis, vulvodynia, endometriosis, irritable bowel syndrome, and temporomandibular joint disorder.  His expertise lies in researching the physiologic mechanisms that underlie symptom expression in patients with chronic pain (i.e., fibromyalgia, interstitial cystitis, etc.) as well as characterizing these patients for both clinical and research purposes.